F. J. Calahorra

Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: relative changes of parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand

P. Esbrit, J. Sarasa, F. Pérez-Martínez, 2006, Journal of Clinical Pathology.

Receptor activator of nuclear factor-kappaB ligand (RANKL) as a novel prognostic marker in prostate carcinoma.

P. Esbrit, J. Sarasa, F. Manzarbeitia, 2008, Histology and histopathology.

Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells.

P. Esbrit, V. Alonso, F. Calahorra, 2009, Life sciences.

Receptor activator of nuclear factor-kappaB ligand (RANKL) as a novel prognostic marker in prostate carcinoma.

P. Esbrit, J. Sarasa, F. Manzarbeitia, 2008, Histology and histopathology.